T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3...

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• T cell activation requires T cell receptor recognition and co-stimulatory signals.
• Activation antigens, like Lymphocyte Activation Gene (LAG)-3, emerge post-priming and may regulate T cell inactivation.
• The interaction between LAG-3 and its counter-receptor, Major Histocompatibility Complex (MHC) class II molecules, is hypothesized to down-regulate immune responses.

Purpose of the Study:

• To investigate the functional role of the interaction between LAG-3 and MHC class II molecules.
• To determine if LAG-3/MHC class II interaction can modulate T cell responses.
• To explore the potential of LAG-3 as a regulator of CD4+ T cell activity.

Main Methods:

• Production of a soluble LAG-3 fusion protein (LAG-3Ig) by linking extracellular LAG-3 domains to human IgG1.
• Assessing the binding specificity of LAG-3Ig to cell surface MHC class II molecules.
• Evaluating the impact of LAG-3/MHC class II interaction on CD4+ T cell proliferation and cytokine secretion using various stimulation methods.

Main Results:

• Demonstrated direct and specific binding of LAG-3Ig to MHC class II molecules on cell surfaces.
• Showed that LAG-3/MHC class II interaction significantly down-regulates proliferation and cytokine secretion in CD4+ T cell clones.
• Confirmed that this inhibitory effect occurs at the effector T cell level, independent of antigen-presenting cells (APCs).

Conclusions:

• The interaction between T cell MHC class II molecules and LAG-3 binding leads to the down-regulation of T cell proliferation.
• LAG-3 plays a significant role in controlling CD4+ T cell responses.
• This study provides insights into LAG-3-mediated immune regulation and its potential therapeutic applications.